Treatment of MRSA Infections in an African-American Male with G6PD Deficiency

Journal of Emergency Medicine

Volumn 37, Issue 3, 2009, Pages 273-278

  Paek, David S ^a   Nadkarni, Milan ^b   Singla, Manav ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Critical Care   (United States)

Author keywords

chronic granulomatous disease (CGD); glucose 6 phosphate dehydrogenase (G6PD); methicillin resistant Staphylococcus aureus (MRSA)

Indexed keywords

CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ABSCESS; ARTICLE; CASE REPORT; CELLULITIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEVER; FURUNCULOSIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; IMMUNE DEFICIENCY; INFANT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AFRICAN AMERICANS; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CLINDAMYCIN; EMERGENCY SERVICE, HOSPITAL; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RECURRENCE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 70349126779     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.10.049     Document Type: Article

References (24)

1. Babior B.M. NADPH oxidase. Curr Opin Immunol 16 (2004) 42-47
2. Ruwende C., and Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med 76 (1998) 581-588
3. Quereshy F.A., Gold E.S., and Powers M.P. Hemolytic anemia in a glucose-6-phosphate dehydrogenase-deficient patient triggered by a maxillofacial infection. J Oral Maxillofac Surg 58 (2000) 805-807
4. Fiorelli G., Martinez di Montemuros, and Cappellini M.D. Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants. Baillieres Best Pract Res Clin Haematol 13 (2000) 39-55
5. Beutler E., and Vulliamy T.J. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 28 (2002) 93-103
6. van Bruggen R., Bautista J.M., Petropoulou T., et al. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100 (2002) 1026-1030
7. Beutler E. G6PD: population genetics and clinical manifestations. Blood Rev 10 (1996) 45-52
8. Cooper M.R., DeChatelet L.R., McCall C.E., LaVia M.F., Spurr C.L., and Baehner R.L. Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest 51 (1972) 769-778
9. Roos D., van Zwieten R., Wijnen J.T., et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 94 (1999) 2955-2962
10. Rutenberg W.D., Yang M.C., Doberstyn E.B., and Bellanti J.A. Multiple leukocyte abnormalities in chronic granulomatous disease: a familial study. Pediatr Res 11 (1977) 158-163
11. Beutler E. G6PD deficiency. Blood 84 (1994) 3613-3636
12. Baird J.K., and Hoffman S.L. Primaquine therapy for malaria. Clin Infect Dis 39 (2004) 1336-1345
13. Brook I. Microbiology of polymicrobial abscesses and implications for therapy. J Antimicrob Chemother 50 (2002) 805-810
14. Iyer S., and Jones D.H. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 50 (2004) 854-858
15. Fridkin S.K., Hageman J.C., Morrison M., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
16. Ochoa T.J., Mohr J., Wanger A., Murphy J.R., and Heresi G.P. Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis 11 (2005) 966-968
17. Kowalski T.J., Berbari E.F., and Osmon D.R. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 80 (2005) 1201-1207
18. Frazee B.W., Lynn J., Charlebois E.D., Lambert L., Lowery D., and Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 45 (2005) 311-320
19. Braun L., Craft D., Williams R., Tuamokumo F., and Ottolini M. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J 24 (2005) 622-626
20. Raghavan M., and Linden P.K. Newer treatment options for skin and soft tissue infections. Drugs 64 (2004) 1621-1642
21. Adra M., and Lawrence K.R. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 38 (2004) 338-341
22. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40 (2005) 562-573
23. th edn. (2005), Antimicrobial Therapy Inc, Sperryville, VA
24. Newman B., Hu W., Nigro K., and Gilliam A.C. Aggressive histiocytic disorders that can involve the skin. J Am Acad Dermatol 56 (2007) 302-316